Literature DB >> 26599568

Etiology of Pneumonia in a Pediatric Population with High Pneumococcal Vaccine Coverage: A Prospective Study.

Are Stuwitz Berg1, Christopher Stephen Inchley, Audun Aase, Hans Olav Fjaerli, Reidun Bull, Ingeborg Aaberge, Truls Michael Leegaard, Britt Nakstad.   

Abstract

BACKGROUND: Improved Childhood Immunizations Programs, especially the introduction of pneumococcal vaccination, better diagnostic methods and the importance of reduced antibiotic misuse, make this a critical time to increase knowledge on the etiology of pediatric pneumonia. Our main objective was to identify the contribution of various microbiological species that causes pneumonia in previously healthy children and adolescents in a population with high pneumococcal conjugate vaccine coverage.
METHODS: This prospective, observational study enrolled patients with clinical and radiological signs of pneumonia over a 2-year period. Both inpatients and outpatients were included. Paired sera, nasopharyngeal polymerase chain reaction and bacterial cultures from blood and pleura were analyzed to detect potential viral and bacterial causative pathogens.
RESULTS: TWO HUNDRED AND SIXTY-FIVE: cases of clinical and radiological verified pneumonia were identified. The pneumococcal vaccine coverage was 85%. We identified a causative pathogen in 84.2% of all cases; 63.4% with single viral etiology, 11.3% with pneumococcus and 7.5% with mycoplasma infection. Respiratory syncytial virus was the most common pathogen in children younger than 5 years, whereas mycoplasma was the most common in older children.
CONCLUSIONS: We identified the majority of 265 cases with radiology proven pneumonia as single viral infections, predominantly respiratory syncytial virus and a much lower proportion of bacterial causes. These findings may impact pneumonia management guidelines in areas where widespread pneumococcal vaccination is provided and contribute to reduced antibiotic overuse in pediatric pneumonia.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26599568     DOI: 10.1097/INF.0000000000001009

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  9 in total

1.  Clinical features and inflammatory markers in pediatric pneumonia: a prospective study.

Authors:  Are Stuwitz Berg; Christopher Stephen Inchley; Hans Olav Fjaerli; Truls Michael Leegaard; Morten Lindbaek; Britt Nakstad
Journal:  Eur J Pediatr       Date:  2017-03-09       Impact factor: 3.183

2.  Combination of clinical symptoms and blood biomarkers can improve discrimination between bacterial or viral community-acquired pneumonia in children.

Authors:  Mejbah U Bhuiyan; Christopher C Blyth; Rachel West; Jurissa Lang; Tasmina Rahman; Caitlyn Granland; Camilla de Gier; Meredith L Borland; Ruth B Thornton; Lea-Ann S Kirkham; Andrew Martin; Peter C Richmond; David W Smith; Adam Jaffe; Thomas L Snelling
Journal:  BMC Pulm Med       Date:  2019-04-02       Impact factor: 3.317

3.  Using a period incidence survey to compare antibiotic use in children between a university hospital and a district hospital in a country with low antimicrobial resistance: a prospective observational study.

Authors:  Christian Magnus Thaulow; Hege Salvesen Blix; Beate Horsberg Eriksen; Ingvild Ask; Tor Åge Myklebust; Dag Berild
Journal:  BMJ Open       Date:  2019-05-27       Impact factor: 2.692

4.  Risk factors associated with severe disease in respiratory syncytial virus infected children under 5 years of age.

Authors:  Lise Beier Havdal; Håkon Bøås; Terese Bekkevold; Anne-Marte Bakken Kran; Astrid Elisabeth Rojahn; Ketil Størdal; Sara Debes; Henrik Døllner; Svein Arne Nordbø; Bjørn Barstad; Elisebet Haarr; Liliana Vázquez Fernández; Britt Nakstad; Christopher Inchley; Elmira Flem
Journal:  Front Pediatr       Date:  2022-08-30       Impact factor: 3.569

5.  The Etiology of Community-Acquired Pneumonia Correlates with Serum Inflammatory Markers in Children.

Authors:  August Wrotek; Julita Robakiewicz; Katarzyna Pawlik; Patryk Rudzinski; Izabela Pilarska; Aleksandra Jaroń; Aleksandra Imiełowska; Małgorzata Jarzębowska; Katarzyna Zabłocka; Teresa Jackowska
Journal:  J Clin Med       Date:  2022-09-20       Impact factor: 4.964

6.  Clinical manifestations in infants and children with Mycoplasma pneumoniae infection.

Authors:  Mia Johanna Søndergaard; Martin Barfred Friis; Dennis Schrøder Hansen; Inger Merete Jørgensen
Journal:  PLoS One       Date:  2018-04-26       Impact factor: 3.240

7.  Epidemiology of hospitalised paediatric community-acquired pneumonia and bacterial pneumonia following the introduction of 13-valent pneumococcal conjugate vaccine in the national immunisation programme in Japan.

Authors:  N Takeuchi; S Naito; M Ohkusu; K Abe; K Shizuno; Y Takahashi; Y Omata; T Nakazawa; K Takeshita; H Hishiki; T Hoshino; Y Sato; N Ishiwada
Journal:  Epidemiol Infect       Date:  2020-04-17       Impact factor: 2.451

8.  Relationship between Maternal and First Year of Life Dispensations of Antibiotics and Antiasthmatics.

Authors:  Guro Haugen Fossum; Morten Lindbæk; Svein Gjelstad; Kari J Kværner
Journal:  Antibiotics (Basel)       Date:  2018-09-17

9.  The contribution of viruses and bacteria to community-acquired pneumonia in vaccinated children: a case-control study.

Authors:  Mejbah Uddin Bhuiyan; Thomas L Snelling; Rachel West; Jurissa Lang; Tasmina Rahman; Caitlyn Granland; Camilla de Gier; Meredith L Borland; Ruth B Thornton; Lea-Ann S Kirkham; Chisha Sikazwe; Andrew C Martin; Peter C Richmond; David W Smith; Adam Jaffe; Christopher C Blyth
Journal:  Thorax       Date:  2018-10-18       Impact factor: 9.139

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.